Gary E. Raskob - Concepedia

Author

Gary E. Raskob

University of Oklahoma Health Sciences Center

Also Known As

Alex S. Gallus, Alexander Cohen, Bruce Davidson, Corinne Frere, G E Raskob, G. Raskob, G.E. RASKOB, G.E. Raskob, Gary E Raskob, Gary E. Raskob

Publications

10K

Citations

H-Index

Concepts

All Affiliations

University of Oklahoma Health Sciences Center Amsterdam UMC Location University of Amsterdam McMaster University Thrombosis and Atherosclerosis Research Institute Flinders Medical Centre

About

Gary E. Raskob is an author at University of Oklahoma Health Sciences Center specializing in medicine, thrombosis, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	783
2	Emergency Medicine	5	5	229
3	Public Health	4	4	164
4	Health Sciences	2	2	217
5	Gastroenterology	1	1	22

Gary E. Raskob

Publications

7.2K

Citations

H-Index

Page 1

	Year	Citations
Oral Apixaban for the Treatment of Acute Venous Thromboembolism Giancarlo Agnelli, Harry R. Büller, Alexander T. Cohen, New England Journal of Medicine	2013	2.2K
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism Gary E. Raskob, Nick van Es, Peter Verhamme, New England Journal of Medicine	2017	1.6K
Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement Michael R. Lassen, Alexander Gallus, Gary E. Raskob, New England Journal of Medicine	2010	769
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis Harry R. Büller, Claudette Bethune, Sanjay Bhanot, New England Journal of Medicine	2014	608
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study Harry R. Büller, Anthonie W.A. Lensing, Martin H. Prins, Blood	2008	345
Abelacimab for Prevention of Venous Thromboembolism Peter Verhamme, B. Alexander Yi, Annelise Segers, New England Journal of Medicine	2021	273
Milvexian for the Prevention of Venous Thromboembolism Jeffrey I. Weitz, John Strony, Walter Ageno, New England Journal of Medicine	2021	235
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial Giancarlo Agnelli, H.R. Büller, Alexander Cohen, Journal of Thrombosis and Haemostasis ThrombosisVenous ThrombosisOncologyHematologyOral Apixaban	2015	195
Dose-Response Study of Recombinant Factor VIIa/Tissue Factor Inhibitor Recombinant Nematode Anticoagulant Protein c2 in Prevention of Postoperative Venous Thromboembolism in Patients Undergoing Total Knee Replacement Agnes Lee, Giancarlo Agnelli, Harry Büller, Circulation	2001	166
Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial Gary E. Raskob, Nick van Es, Annelise Segers, The Lancet Haematology ThrombosisPulmonary EmbolismVenous ThrombosisMedicineDouble-dummy Trial	2016	154

Page 1